2011 Annual Meeting | Research Coordinator Colloquium
| 02:00 PM - 02:05 PM |
Welcome
Petra Kaufmann, MD, FAAN |
|
| 02:05 PM - 02:30 PM |
Approaches to Implementing Multicenter Trials
Cornelia Kamp |
|
| 02:30 PM - 02:35 PM |
Questions and Answers
|
|
| 02:35 PM - 03:00 PM |
Recruitment and Retention in Neuroscience Clinical Trials
Karla P. Figueroa |
|
| 03:00 PM - 03:05 PM |
Questions and Answers
|
|
| 03:05 PM - 03:25 PM |
Implementing Trials: The Investigator Perspective
Michael G. Benatar, MBChB, DPhil, FAAN |
|
| 03:25 PM - 03:40 PM |
Career Opportunities and Pathways in Neuroscience Clinical Research
Karla P. Figueroa, Cornelia Kamp, Carly Siskind, MS |
|
| 03:40 PM - 04:00 PM |
Clinical Research Team Members and the AAN: Next Steps
Petra Kaufmann, MD, FAAN |
|
| 04:00 PM - 05:00 PM |
Post-Colloquium Networking
|
| Petra Kaufmann, MD, FAAN | Dr. Kaufmann has received personal compensation for serving as an employee of Affinia Therapeutics. Dr. Kaufmann has received personal compensation for serving as an employee of Vigil Neuroscience. Dr. Kaufmann has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for DTx. Dr. Kaufmann has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Taysha Gene Therapies. Dr. Kaufmann has stock in Vigil Neuroscience. The institution of an immediate family member of Dr. Kaufmann has received research support from Cystic Fibrosis Foundation . Dr. Kaufmann has a non-compensated relationship as a Member of a Scientific Advisory Board with NIH that is relevant to AAN interests or activities. |
| Karla P. Figueroa | Ms. Figueroa has nothing to disclose. |
| Michael G. Benatar, MBChB, DPhil, FAAN | Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Arrowhead. Dr. Benatar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Benatar has received personal compensation in the range of $0-$499 for serving as a Consultant for Annexon. Dr. Benatar has received personal compensation in the range of $0-$499 for serving as a Consultant for UniQure. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cartesian. Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Benatar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CorEvitas. Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Canopy. Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alaunos. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Prilenia. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alector. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BMS. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Woolsey. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Benatar has received intellectual property interests from a discovery or technology relating to health care. |
| Carly Siskind, MS | No disclosure on file |
| Cornelia Kamp | No disclosure on file |